Insiders · Profile

Astle Christopher

SVP & Chief Financial Officer at Zymeworks. Filing since 12 Dec 2022. CIK 0001915257

Company
Date
Role
Action
Shares
Amount
Of holding
8 Jan 2024
SVP & Chief Financial Officer
Sold at will
1,431
$16.05K
18.0%
5 Jan 2024
SVP & Chief Financial Officer
Sold at will
4,563
$48.61K
36.5%
11 Dec 2023
SVP & Chief Financial Officer
Sold at will
886
$8.09K
30.7%
12 Dec 2022
SVP & Chief Financial Officer
Sold, plan not stated
887
$5.33K
40.0%
4 decisions on file.